Replies to post #43 on Revelation Biosciences Inc (REVB)

[subslover]

Revelation Biosciences (NASDAQ: REVB) stock is up 130% premarket this morning on no really obvious news releases. This follows a 27% price rise in REVB stock yesterday. This is, of course, nice for those stockholders who were in the SPAC process, who have lost 93% of their money since the combination back in January. The question is, well, what's driving this stock price rise? There is no obvious news release to explain it, so we'll have to make some surmises.

Revelation is a clinical-stage biopharmaceutical company focussing on immune system therapeutics and diagnostics. So, there's significant effort and business opportunity in covid, influenza, rhinosinusitis and so on. So far so good, although there doesn't seem to have been any grand announcement about anything from the FDA to explain suh a stock price rise.

[trendzone]

They have been having some positive data updates recently, on its hay fever treatment intranasal REVTx-99b,perhaps some upcoming positive data was leaked to certain institutions that decided they wanted in no mater what, and apparently yesterday's after hours action ment something,when traders were able to buy at $0.65 to $0.87, today's premarket high $1.60 to $1.90, I have been in since early April and average down on it five times, with buys below $0.50, also added more after hours at $0.75,so for me the after hours action meant something, and it paid off.